Grosu Irina, Lavand'homme Patricia
Department of Anesthesiology, Saint-Luc Hospital Medical School, Université Catholique de Louvain Avenue Hippocrate 10-1821, B-1200 Brussels Belgium.
F1000 Med Rep. 2010 Dec 17;2:90. doi: 10.3410/M2-90.
For many years, clonidine, an α2-adrenergic receptor (α2-AR) agonist, has been widely used as an analgesic adjuvant in perioperative conditions and pain therapy. Dexmedetomidine (DMET) is currently the most potent α2-AR agonist available and was first approved as a sedative agent for use in the intensive care unit. However, DMET has recently been investigated for its analgesic effects and has the potential to become an alternative to clonidine.
多年来,可乐定,一种α2肾上腺素能受体(α2-AR)激动剂,已被广泛用作围手术期和疼痛治疗中的镇痛辅助药物。右美托咪定(DMET)是目前可用的最有效的α2-AR激动剂,最初被批准用作重症监护病房的镇静剂。然而,最近对DMET的镇痛作用进行了研究,它有潜力成为可乐定的替代品。